NASDAQ:DRMAW

Dermata Therapeutics Stock Forecast

etoro logo Buy DRMAW
*Your capital is at risk
$0.0126
+0 (+0%)
At Close: Jun 26, 2026
AI Analysis AI Analysis of DRMAW AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add DRMAW to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Dermata Therapeutics, Inc. stock upgraded to Hold/Accumulate
(Updated on Jun 26, 2026)

Hold candidate since Jun 26, 2026

No changes to the price of Dermata Therapeutics, Inc. stock on the last trading day (Friday, 26th Jun 2026). During the last trading day the stock fluctuated 0% from a day low at $0.0126 to a day high of $0.0126. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -27.53% during the next 3 months and, with a 90% probability hold a price between $0.0059 and $0.0100 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

DRMAW Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Dermata Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0126 and $0.0130. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Dermata Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0114 and $0.0110. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Dermata Therapeutics, Inc. finds support just below today's level at $0.0114. If this is broken, then the next support from accumulated volume will be at $0.0110 and $0.0102.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 51.15%

Our recommended stop-loss: $0.0118 (-6.10%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (DRMAW) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Dermata Therapeutics, Inc. to open at $0.0126, and during the day (based on 14 day Average True Range), to move between $0.0098 and $0.0154, which gives a possible trading interval of +/-$0.0056 (+/-57.37%) up or down from last closing price. If Dermata Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 57.37% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0114 (9.52%) than the resistance at $0.0144 (14.29%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Dermata Therapeutics, Inc. stock A Buy?

Dermata Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $0.0126 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

DRMAW Performance

Trading levels for DRMAW

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0126 -
R2 0.0126 -
R1 0.0126 -
Price 0.0126
S1 0.0126 -
S2 0.0126 -
S3 0.0126 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0154 22.23%
R2 0.0147 16.67%
R1 0.0144 14.29%
Price 0.0126
S1 0.0114 -9.52%
S2 0.0110 -12.70%
S3 0.0102 -19.05%

FAQ

What is the symbol for Dermata Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Dermata Therapeutics, Inc. is DRMAW and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Dermata Therapeutics, Inc. Stock?
Dermata Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Dermata Therapeutics, Inc. Stock?
Dermata Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Dermata Therapeutics, Inc. Stock.

What's the current price of Dermata Therapeutics, Inc. Stock?
As of the end of day on the Jun 26, 2026, the price of an Dermata Therapeutics, Inc. (DRMAW) share was $0.0126.

What is the 52-week high and low for Dermata Therapeutics, Inc. Stock?
The 52-week high for Dermata Therapeutics, Inc. Stock is $0.0290 and the 52-week low is $0.0100.

What is the market capitalization of Dermata Therapeutics, Inc. Stock?
As of the Jun 26, 2026, the market capitalization of Dermata Therapeutics, Inc. is 8.588K.

When is the next earnings date for Dermata Therapeutics, Inc.?
The upcoming earnings date for Dermata Therapeutics, Inc. is Aug 18, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
JLL
$299.78
5.10% Jun 24
X
XMAX
$8.34
5.40% Jun 24
TWI
$7.56
6.08% Jun 22
IAC
$42.63
5.08% Jun 12
DHI
$146.71
13.35% Jun 10

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE